about
Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonistsHighlights on the development of A(2A) adenosine receptor agonists and antagonistsIdentification of alpha1-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferensAdenosine deaminase: functional implications and different classes of inhibitors.Deaza- and deoxyadenosine derivatives: synthesis and inhibition of animal viruses as human infection models.Solid phase synthesis and antiprotozoal evaluation of di- and trisubstituted 5'-carboxamidoadenosine analogues.Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1.Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: synthesis, structure-affinity relationships and molecular modeling studies.Neuropeptide S receptor: recent updates on nonpeptide antagonist discovery.Development of new chromatographic tools based on A2A adenosine receptor subtype for ligand characterization and screening by FAC-MS.Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17.Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family.Erratum to: Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A(3) adenosine receptor ligandsSimulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptorIntroduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor.Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch.2- and 8-alkynyladenosines: conformational studies and docking to human adenosine A3 receptor can explain their different biological behavior.Purine and deazapurine nucleosides: synthetic approaches, molecular modelling and biological activity.9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities.Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists.Effects of 5'-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors.Synthesis and biological activity of trisubstituted adenines as A 2A adenosine receptor antagonists.Synthesis and stability studies of 2',3',5'-tri-O-acetyl-2-amino(-N6-cyclopentyl)-1-deazaadenosines.Effects of A₂A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats.A2A adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.[3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.Synthesis and evaluation of hexitol nucleoside congeners as ambiguous nucleosidesSynthesis of a conformationally restricted analogue of paclitaxelA taxane epoxide from Taxus wallichiana
P50
Q28205924-36F5EAA1-1F68-411D-8110-24A067509816Q28279556-566D833F-A72D-4B99-BD0E-ED7912627EEAQ28572601-5AC7E646-53DE-4515-B348-1E3AB101BE20Q32063453-240C8514-82B7-4FD2-8E1C-D032112A6CD6Q33194019-144E7D42-1856-48C2-8794-82188EEEC6DFQ33225956-B14CA2E1-29EE-40BD-B098-EC665238BEBFQ33556111-C6EBBF4A-A25A-4CDE-ACFC-938DB703CA90Q33830451-25C1E8F5-7628-4626-9CA6-DBA2F692A1BBQ34484854-D645B53C-56AC-4F23-A10D-93A5577C38BBQ37859670-FC762F50-BD8B-4236-BD0A-92746437ABBEQ39282843-55D56874-6BAF-4C14-939F-118AC53CE882Q39393180-060A3117-37E4-431C-8B65-0405E43E7170Q39803514-2C0517A0-8756-4E82-8C1B-E0ACD018FE61Q40729657-D197C506-6AE3-4943-A670-26D39808A470Q41692310-1409AF75-5CDA-4E16-A2AA-5000AE1AED2CQ42507509-621DA069-D856-46AF-90E6-7AD01142AF6FQ43259118-49A236AD-4C44-4A05-939D-5802647D1978Q43988446-452BA1E1-39C4-4A51-BD0C-38B475BB103DQ44247309-CBA6F052-0E13-4188-87CF-E8A35646CC2CQ44349398-E935F4A0-7E6D-4531-948B-40B4E53A9261Q44432277-21192EF9-67A3-4C4F-9939-4DABB18AD6BBQ45331430-030D9053-AC66-43ED-8181-E65CB3E86BA1Q46436392-AAEDD291-2CA9-484C-8A94-D4971187C1E2Q46860700-B3281011-D991-4C3D-B06E-66B820473A69Q46860703-2E7DEE62-7234-4796-B457-09C214E4EE8AQ48807094-E0C40B09-4CCB-4D81-A396-EED008D351FEQ51329119-29E13531-83BD-4FAF-9359-807BC0BDD8C5Q51799623-A7F6B6D8-F31B-49CD-96DA-7DFB0ED27FF6Q51801874-FA72ED72-949F-4EA0-8564-FE3D9F4DE2E1Q57082339-7C7B2BF0-E1A4-4832-AD95-95175B7862E2Q60684477-583A0473-F230-48AD-9FDA-654AED456AEFQ60684481-61E17E4F-B683-494D-BB5F-28D4C47DCFBC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Catia Lambertucci
@ast
Catia Lambertucci
@en
Catia Lambertucci
@es
Catia Lambertucci
@nl
Catia Lambertucci
@sl
type
label
Catia Lambertucci
@ast
Catia Lambertucci
@en
Catia Lambertucci
@es
Catia Lambertucci
@nl
Catia Lambertucci
@sl
prefLabel
Catia Lambertucci
@ast
Catia Lambertucci
@en
Catia Lambertucci
@es
Catia Lambertucci
@nl
Catia Lambertucci
@sl
P106
P21
P31
P4012
P496
0000-0003-2004-1531